×

Growth Reports

Growth Reports
Report Name

Women's Healthcare Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Drug (XGEVA, Mirena, EVISTA, Prolia, Zometa, Reclast/Aclasta, Minastrin 24 Fe, NuvaRing, Premarin, FORTEO, ACTONEL, Others), By Application (Postmenopausal Osteoporosis, Menopause, Endometriosis, Hormonal Infertility, Contraceptives, Others), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online providers), Countries and Companies Report

Women's Healthcare is projected to register a 5.3% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00024505  |   No. of Pages: 205

Whole Exome Sequencing Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Instruments, Consumables, Services), By Technology (Sequencing By Synthesis (ION Semiconductor Sequencing, Others), By Workflow (Pre-Sequencing, Sequencing, Data Analysis), By Application (Clinical Diagnostics, Drug Discovery & Development, Personalized Medicines, Others), By End-User (Academic & Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others), Countries and Companies Report

Whole Exome Sequencing is projected to register a 16.3% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00024504  |   No. of Pages: 205

Wellness Supplements Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Dietary Supplements, Functional Food & Beverages, Food Intolerance products, Dermo-Cosmetic Skin Essentials), By Application (Home Care, Hospitals, Others), Countries and Companies Report

Wellness Supplements is projected to register a 6.1% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00024503  |   No. of Pages: 205

Weight Loss Management Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Weight Loss Diet, Fitness Equipment, Surgical Equipment), By Application (Fitness Centers, Slimming Centers, Consulting Services, Online Weight Loss Programs), By Diet (DASH diet, Mediterranean diet, Ketogenic diet, Plant-based diet, Others), Countries and Companies Report

Weight Loss Management is projected to register a 7.2% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00024502  |   No. of Pages: 205

Weight Loss and Diet Management Products and Services Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Meals, Beverages, Supplements), By Application (Weight Loss Surgery, MDs, Hospitals/Clinic Programs, Rx Diet Drugs, Bariatricians, VLCD Programs), Countries and Companies Report

Weight Loss and Diet Management Products and Services is projected to register a 7.8% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00024501  |   No. of Pages: 205

Weight Loss and Diet Management Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Diet (Weight Loss Supplements, Meal Replacements, Low-Calorie Sweeteners, Others), By Equipment (Fitness Equipment, Surgical Equipment), By Service (Fitness Center, Slimming Centers, Online Weight Loss Programs, Others), By Application (Online Distribution, Health And Beauty Stores, Others), Countries and Companies Report

Weight Loss and Diet Management is projected to register a 8.2% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00024500  |   No. of Pages: 205

VNA and PACS Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Imaging Modality (Angiography, Mammography, Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Others), By Type (PACS, VNA Software), By Mode of Delivery (On-Site, Hybrid, Cloud-hosted), By Usage Model, Single Department, Multiple Departments, Multiple Sites), Countries and Companies Report

VNA and PACS is projected to register a 6.7% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00024499  |   No. of Pages: 205

Vital Signs Monitoring Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Consumer Wearables, Medical Device), By End-User (Hospitals and Clinics, Ambulatory and Health centers, Home care), Countries and Companies Report

Vital Signs Monitoring is projected to register a 7.2% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00024498  |   No. of Pages: 205

Virology Specimen Collection Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Blood Collection Kits, Specimen Collection Tubes, Viral Transport Media, Swabs), By Sample (Blood Samples, Nasopharyngeal Samples, Throat Samples, Nasal Sampls, Cervical Samples, Oral Samples, Others), Countries and Companies Report

Virology Specimen Collection is projected to register a 5.6% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00024497  |   No. of Pages: 205

Viral Vector and Plasmid DNA Manufacturing Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Viral Vectors, Plasmid DNA), By Products and Services (Product, Services), By Workflow (Upstream Manufacturing, Downstream Manufacturing), By Application (Cell and Gene Therapy, Vaccine Development, Research), By Disease (Cancer, Generic Disorders, Infectious Diseases, Others), By End-User (Pharmaceutical and Biopharmaceutical Companies, Academics and Research Institutes, Others), Countries and Companies Report

Viral Vector and Plasmid DNA Manufacturing is projected to register a 13.5% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00024496  |   No. of Pages: 205

USD Analytics

USD Analytics is a leading information and analytics provider for customers across industries worldwide.


Useful Links

Contact Us